HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average.
Saved in:
| Title: | HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average. |
|---|---|
| Authors: | Labban, M1 (AUTHOR), Mali, P1 (AUTHOR), Jao, R1 (AUTHOR), Patel, P1 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS473-S474. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2022.04.966 |
